Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Atomico
AddedFeb 13, 2024
UpdatedJun 30, 2026
Atomico

Atomico

Operating

Atomico: A leading European venture capital firm, founded by Skype co-founder, Niklas Zennström.

Location
London, Greater London, GB
Founded
2006
Firm
Compare
Portfolio
Employees
News
Website

Latest News About Atomico

The groupthink boom: what 3 top VCs really think about the AI frenzy

TechCrunch

The groupthink boom: what 3 top VCs really think about the AI frenzy

"If you're 22 years old in San Francisco and building something in AI, there may be a seed term sheet in your inbox — but if you're 19, oh...

May 30, 2026

European tech gets political

TechCrunch

European tech gets political

Taking a page from Big Tech, legacy industries, and their U.S. peers, European tech companies are increasingly learning to lobby for...

Nov 19, 2025

Defiant is a new European VC firm that uses data and products to make better investments

TechCrunch

Defiant is a new European VC firm that uses data and products to make better investments

Defiant is a new early stage VC firm focused on B2B SaaS and fintech coming out of stealth today. Joseph Pizzolato (pictured right) and Cam...

Jan 9, 2025

Atomico backs Tem to help businesses buy renewable energy directly from sources

TechCrunch

Atomico backs Tem to help businesses buy renewable energy directly from sources

A U.K. startup wants to do for utilities what neobanks have been doing for the financial sector for more than a decade: disrupt an age-old...

Sep 11, 2024

European VC Atomico closes $1.24B across two funds for early and growth-stage startups

TechCrunch

European VC Atomico closes $1.24B across two funds for early and growth-stage startups

Sep 8, 2024

Healx, an AI-enabled drug discovery platform for rare diseases, raises $47M

TechCrunch

Healx, an AI-enabled drug discovery platform for rare diseases, raises $47M

The company also said it has received regulatory clearance to start Phase 2nclinical trials for a new drug in the U.S. later this year.

Aug 1, 2024